HolderBook

ACADIA PHARMACEUTICALS INC (ACAD)

Institutional ownership reported to the SEC as of Q3 2026, across 32 quarters.

10
Reporting holders
$1.4M
Reported value
0.0%
Calls
0.0%
Puts
-346
Holder change

Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.

Holders

Download these holders as CSV

FilerValueShares Their book Held Change
Gradient Investments LLC$636.6K31,5930.01%3q-3.5%-$23.1K
Valeo Financial Advisors, LLC$423.8K21,0330.01%newNEW
Farther Finance Advisors, LLC$181.8K9,0230.00%16q+996.4%+$165.2K
GAMMA Investing LLC$81.9K4,0640.00%12q+36.1%+$21.7K
Versant Capital Management, Inc$19.6K9740.00%8q+4.1%
Grove Bank & Trust$4.0K2000.00%16qHELD
MassMutual Private Wealth & Trust, FSB$1.2K620.00%6qHELD
Marquette Asset Management, LLC$847420.00%4qHELD
GILPIN WEALTH MANAGEMENT, LLC$383190.00%4qHELD
Davis Capital Management$242120.00%2q+71.4%

Five percent filings

Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →

FiledFormFiler % of class
2026-08-0713GSTATE STREET CORPORATION5.3%

What the insiders did

Open market purchases and sales reported on Form 4 in the last 180 days. Grants, option exercises and shares surrendered to cover tax are left out: they are compensation rather than a decision to buy or sell. Where a broker filled one order in tranches the lines are summed, because it was one decision.

Officers and directors

DateInsiderRoleSideSharesValue
2026-07-30Thompson Elizabeth H.Z.EVP, Head of Research & DevSold16,558$432.7K ×2
2026-08-06Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSold14,292$417.6K ×2
2026-06-26Kihara JamesPRINCIPAL ACCOUNTING OFFICERSold11,421$297.9K
2026-08-05Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSold5,849$169.6K
2026-05-26Kihara JamesPRINCIPAL ACCOUNTING OFFICERSold5,401$114.4K

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q3 202610$1.4M67,0221410.0%
Q2 2026356$4.7B185,881,333491361090.3%
Q1 2026344$3.7B165,900,698361111260.6%
Q4 2025339$4.5B167,048,315361231110.3%
Q3 2025349$3.7B168,443,985591191071.7%
Q2 2025317$3.7B171,132,50348901220.7%
Q1 2025322$2.9B173,383,424621011011.2%
Q4 2024297$3.0B163,867,38754104730.9%
Q3 2024261$2.5B157,789,6573588770.9%
Q2 2024266$2.7B162,624,23236102790.8%
Q1 2024272$3.2B166,299,9104997702.5%
Q4 2023279$5.1B162,051,9535098681.2%
Q3 2023251$3.4B156,462,4204386672.7%
Q2 2023240$3.8B159,292,2363375740.5%
Q1 2023236$3.1B166,125,2773775640.5%
Q4 2022227$2.8B173,222,6002574730.6%
Q3 2022225$2.5B152,422,1512377670.7%
Q2 2022249$2.2B150,949,6983766872.0%
Q1 2022266$3.6B147,084,8554676831.5%
Q4 2021251$3.6B150,340,0913767923.4%
Q3 2021236$2.4B144,839,4672872791.2%
Q2 2021246$3.7B148,042,2733983711.7%
Q1 2021272$3.9B145,386,78247104803.7%
Q4 2020306$8.0B148,049,2436187911.5%
Q3 2020266$6.3B150,054,0094798881.2%
Q2 2020302$7.5B152,957,7907976961.1%
Q1 2020249$6.6B155,404,4393383831.2%
Q4 2019278$6.7B151,696,4866394792.6%
Q3 2019235$5.5B147,796,2896671622.4%
Q2 2019201$3.9B139,075,6373347745.2%
Q1 2019203$3.8B137,893,9853765611.6%
Q4 2018188$2.3B140,927,1906422.3%